Suncoast Ventures

Bloomlife provides a remote monitoring platform for high-risk pregnancies, tracking conditions like hypertension and diabetes. It is developing an FDA-cleared at-home fetal non-stress test for Medicaid, rural, and underserved populations.

ClinNEXUS offers Enhanced Care Management for Medicaid populations under California’s CalAIM, combining clinical, social, and behavioral support with AI and data science.

CRISPR QC brings real-time quality control into gene-editing workflows, turning a slow, opaque 'black box' process into one that is measurable, predictable, and dramatically faster. Its SaaS platform and chip make CRISPR safe and scalable for therapeutic applications.

NEXT Life Sciences is developing Plan A, a long-acting, non-hormonal male contraceptive in clinical trials. Its platform targets reproductive-health programs like endometriosis in underserved markets.

How deep understanding of payers and policy in California built the most profitable enhanced care management company in the industry.

Childbirth remains one of the most dangerous and under-innovated moments in healthcare. Despite billions spent annually on hospital obstetrics, maternal mortality in the United States continues to rise.

How Sober Sidekick built the largest peer-to-peer recovery community and became the #1 fastest growing product in North America — backed by Suncoast Ventures from the earliest days.

Research and papers from the Suncoast Ventures team and its partners — health economics, the care economy, women's health, and HEOR.

Founder & General Partner

CFO

Venture Partner

Suncoast Ventures — an early-stage healthcare venture firm.

How suncoastvc.com uses cookies — essential only, no tracking.

How Suncoast Ventures handles information collected through suncoastvc.com.

The terms that govern use of suncoastvc.com.